Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe
Authors
Keywords
-
Journal
Applied Health Economics and Health Policy
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-23
DOI
10.1007/s40258-021-00678-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Managed Entry Agreements: Policy Analysis From the European Perspective
- (2020) Monique Dabbous et al. VALUE IN HEALTH
- The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries
- (2020) Bertalan Németh et al. Expert Review of Pharmacoeconomics & Outcomes Research
- European cooperation in health technology assessment implementation: the perspective of Central and Eastern European countries
- (2020) Bertalan Németh et al. Journal of Comparative Effectiveness Research
- Proposal for a regulation on health technology assessment in Europe – opinions of policy makers, payers and academics from the field of HTA
- (2019) Patricia Vella Bonanno et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Waste in the US Health Care System
- (2019) William H. Shrank et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
- (2017) Alessandra Ferrario et al. PHARMACOECONOMICS
- Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review
- (2017) Paweł Kawalec et al. Frontiers in Pharmacology
- Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
- (2017) Paweł Kawalec et al. Frontiers in Pharmacology
- Pharmaceutical expenditure dynamics in the Balkan countries
- (2017) Ana V. Pejcic et al. JOURNAL OF MEDICAL ECONOMICS
- How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries
- (2017) Sabine Vogler et al. Applied Health Economics and Health Policy
- Use of Health Technology Assessment Agencies' Reports As Evidence For Making Decisions On Drug Reimbursement In Decentralized Decision-Making Environment
- (2016) M. Mahmic-Kaknjo et al. CLINICAL THERAPEUTICS
- Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study
- (2016) Sabine Vogler et al. LANCET ONCOLOGY
- Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force
- (2016) Kevin Marsh et al. VALUE IN HEALTH
- Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force
- (2016) Praveen Thokala et al. VALUE IN HEALTH
- Evolution of the Serbian pharmaceutical market alongside socioeconomic transition
- (2015) Mihajlo B Jakovljevic et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The Effect of Decentralised Public Health Care Provision on Accessibility To Medicines in Bosnia And Herzegovina
- (2014) B. Melck et al. VALUE IN HEALTH
- Higher US Branded Drug Prices And Spending Compared To Other Countries May Stem Partly From Quick Uptake Of New Drugs
- (2013) Panos Kanavos et al. HEALTH AFFAIRS
- Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries
- (2013) Christine Leopold et al. HEALTH POLICY
- Reimbursement Restriction and Moderate Decrease in Benzodiazepine Use in General Practice
- (2012) J. M. Hoebert et al. ANNALS OF FAMILY MEDICINE
- Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
- (2012) András Inotai et al. BMC HEALTH SERVICES RESEARCH
- How do patient characteristics influence informal payments for inpatient and outpatient health care in Albania: Results of logit and OLS models using Albanian LSMS 2005
- (2011) Sonila Tomini et al. BMC PUBLIC HEALTH
- Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
- (2011) Sabine Vogler et al. CROATIAN MEDICAL JOURNAL
- European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment
- (2009) Finn Børlum Kristensen et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Health reform in central and eastern Europe and the former Soviet Union
- (2009) Bernd Rechel et al. LANCET
- Health Insurance Coverage In Central And Eastern Europe: Trends And Challenges
- (2008) Hugh R. Waters et al. HEALTH AFFAIRS
- International Prices And Availability Of Pharmaceuticals In 2005
- (2008) Patricia M. Danzon et al. HEALTH AFFAIRS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now